Cargando…
Metabolomics : a path towards personalized medicine /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; San Diego, CA :
Academic Press, an imprint of Elsevier,
[2023]
|
| Colección: | Developments in applied microbiology and biotechnology
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Chapter 1 Personalized medicine; 1.1 Introduction and historical perspective; 1.2 Conventional medicine vs. personalized medicine; 1.3 Enabling technologies; 1.4 The potential of personalized medicine; 1.5 Implementing personalized medicine in clinical practice: Policies, regulation, support, and challenges; 1.6 The cost-effectiveness of personalized medicine; 1.7 The future of personalized medicine
- Chapter 2 Metabolomics for personalized medicine; 2.1 Introduction; 2.2 Technological platforms to measure metabolites; 2.3 Metabolomic workflow for personalized medicine; 2.4 Current challenges of metabolomics for personalized medicine; 2.5 Conclusion
- Chapter 3 Metabolomics in clinical diagnosis, prognosis, and treatment of infectious diseases; 3.1 Introduction; 3.2 Metabolomics analytical approaches in infectious diseases; 3.3 Metabolomics in diagnosis, prognosis, and management; 3.4 Metabolomics for treatment strategy of infectious diseases; 3.5 Conclusions and future perspectives
- Chapter 4 Metabolomics used in clinical diagnosis related to newborn screening; 4.1 Introduction; 4.2 Diagnosis and screening of newborn disorders; 4.3 Newborn disorders; 4.4 Management and treatment of IEM; 4.5 Current challenges with newborn genomic screening (NBGS); 4.6 Potential solution for NBGS; 4.7 Conclusion
- Chapter 5 Metabolic biomarkers in cancer; 5.1 Introduction; 5.2 Leukemia cancer; 5.3 Ovarian cancer; 5.4 Lung cancer; 5.5 Breast cancer; 5.6 Liver cancer; 5.7 Cancer cachexia; 5.8 Summary; Acknowledgments
- Chapter 6 Magnetic resonance imaging in personalized medicine; 6.1 Introduction; 6.2 Magnetic resonance imaging; 6.3 Nanoparticle in magnetic resonance imaging; 6.4 Theranostic use of nanoparticles in diseases; 6.5 Conclusion
- Chapter 7 Metabolomics of diabetes and cardiovascular disease; 7.1 Introduction; 7.2 Metabolomics; 7.3 Techniques for metabolites detection; 7.4 Workflow for metabolomics; 7.5 Metabolomics in biomarker identification; 7.6 Current challenges; 7.7 Conclusion
- Chapter 8 Industrial application of metabolomics for personalized medicine: Current status and challenges; 8.1 Introduction; 8.2 Global market for personalized medicine; 8.3 Instruments contributing to personalized medicine; 8.4 Metabolic biomarkers and therapeutics; 8.5 Diagnostics; 8.6 Challenges at industrial levels for personalized medicine; 8.7 Conclusion